Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct gene expression profiles in blood-brain barrier capillary endothelial cells between mice and humans.

Microvascular research·2026
Same author

Loss of meningeal lymphatic endothelial cells results in formation of a newly forming vascular network with scavenging function.

Development (Cambridge, England)·2026
Same author

Loss of angiopoietin-2 leads to region-specific brain malformations and blood-brain barrier leakage.

JCI insight·2026
Same author

Extracellular RNA in iron-induced hepatic injury: Beyond TLR3 toward an integrated inflammatory axis.

Toxicology reports·2025
Same author

Distinguishing subtypes of endothelial cells in the mouse aorta.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

A comprehensive molecular atlas of the mesenchymal cell types in the mouse liver.

EMBO reports·2025

Related Experiment Video

Updated: Jun 23, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and

Lars Muhl1, Karin Hersemeyer, Klaus T Preissner

  • 1Institute for Biochemistry, Medical School, Justus-Liebig-University Giessen, Giessen, Germany.

FEBS Letters
|May 19, 2009
PubMed
Summary

Factor VII activating protease (FSAP) activity is regulated by its structure, with active forms decreasing cell viability. Inactive FSAP variants are secreted effectively, highlighting structural importance in disease-associated protease function.

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Related Experiment Videos

Last Updated: Jun 23, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Factor VII activating protease (FSAP) is implicated in cardiovascular diseases and liver fibrosis.
  • Understanding FSAP's proteolytic activity regulation is crucial for disease insights.

Purpose of the Study:

  • To characterize recombinant FSAP mutants and elucidate the regulation of its proteolytic activity.
  • To investigate the impact of FSAP variants on cell viability and secretion.

Main Methods:

  • Over-expression of recombinant FSAP mutants in HEK-293 cells.
  • Measurement of secreted FSAP protein concentration and enzymatic activity.
  • Assessment of cell viability following FSAP variant expression.

Main Results:

  • Secreted FSAP concentration inversely correlated with enzymatic activity.
  • Active FSAP over-expression reduced cell viability; inactive variants were secreted well.
  • The G534E variant showed reduced proteolytic activity, and DeltaEGF-3 mutant had impaired heparin binding/activation.

Conclusions:

  • FSAP activity regulation is dependent on its EGF-3 domain.
  • Over-expression of active FSAP variants induces cell death, suggesting a role in pathogenesis.